Australian Clinical Labs Ltd (AU:ACL) has released an update.
JPMorgan Chase & Co. and its affiliates have increased their substantial holding in Australian Clinical Labs Ltd, with voting power rising from 5.27% to 6.36% due to recent share transactions. This change occurred on June 24, 2024, as reported in a notice of change of interests filed with the company. The adjustments in holdings include securities on loan, securities under a lending agreement, and rehypothecation of client securities.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
